Cost-effectiveness analysis of liposomal irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
| Published in: | Expert Review of Pharmacoeconomics & Outcomes Research pp. 1 - 10 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
Taylor & Francis Ltd
Aug2026
|
| Online Access: | View this record in EBSCOhost |